Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Thomas

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Nanotechnology|May 7, 2009
Bio-conjugated luminescent quantum dots of doped ZnS: a cyto-friendly system for targeted cancer imagingKoyakutty Manzoor, Seby Johny, Deepa Thomas, et al.
Nutrients|January 21, 2023
Pharmacological and Molecular Insight on the Cardioprotective Role of ApigeninShilu Deepa Thomas, Niraj Kumar Jha, Saurabh Kumar Jha, et al.
Journal of Basic and Clinical Physiology and Pharmacology|April 28, 2015
Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stressDeepa Thomas, Sindhu Govindhan, Edathiruthykottuckkal Chandran Baiju, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|June 26, 2025
Survey measures of subjective response to alcohol are improved by incorporating questions about the intensity of alcohol effectsFrances L Wang, Sanjana Das, Deepa Thomas, et al.
Journal of Family Medicine and Primary Care|November 7, 2014
Knowledge of common problems of newborn among primi mothers admitted in a selected hospital for safe confinementK C Leena, Deepthi A Koshy, Denna Thankachen, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum DisorderShilu Deepa Thomas, Hend Abdulaziz Mohammed, Mohammad I K Hamad, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum DisorderShilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Frontiers in Behavioral Neuroscience|February 16, 2026
Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in miceWajd Ebdah, Shilu Deepa Thomas, Nermin Eissa, et al.
International Journal of Molecular Sciences|January 8, 2023
Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in MiceNermin Eissa, Mohamed Al Awad, Shilu Deepa Thomas, et al.
Bioengineered|November 25, 2021
Bacterial nanocellulose: engineering, production, and applicationsReshmy R, Eapen Philip, Deepa Thomas, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Nanotechnology|May 7, 2009
Bio-conjugated luminescent quantum dots of doped ZnS: a cyto-friendly system for targeted cancer imagingKoyakutty Manzoor, Seby Johny, Deepa Thomas, et al.
Nutrients|January 21, 2023
Pharmacological and Molecular Insight on the Cardioprotective Role of ApigeninShilu Deepa Thomas, Niraj Kumar Jha, Saurabh Kumar Jha, et al.
Journal of Basic and Clinical Physiology and Pharmacology|April 28, 2015
Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stressDeepa Thomas, Sindhu Govindhan, Edathiruthykottuckkal Chandran Baiju, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|June 26, 2025
Survey measures of subjective response to alcohol are improved by incorporating questions about the intensity of alcohol effectsFrances L Wang, Sanjana Das, Deepa Thomas, et al.
Journal of Family Medicine and Primary Care|November 7, 2014
Knowledge of common problems of newborn among primi mothers admitted in a selected hospital for safe confinementK C Leena, Deepthi A Koshy, Denna Thankachen, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum DisorderShilu Deepa Thomas, Hend Abdulaziz Mohammed, Mohammad I K Hamad, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum DisorderShilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Frontiers in Behavioral Neuroscience|February 16, 2026
Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in miceWajd Ebdah, Shilu Deepa Thomas, Nermin Eissa, et al.
International Journal of Molecular Sciences|January 8, 2023
Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in MiceNermin Eissa, Mohamed Al Awad, Shilu Deepa Thomas, et al.
Bioengineered|November 25, 2021
Bacterial nanocellulose: engineering, production, and applicationsReshmy R, Eapen Philip, Deepa Thomas, et al.
Pageof 3